| Date Filed | Type | Description |
| 08/25/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 35,000 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Khattar Jack A. (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 05/12/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 15,005 shares
@ $36.47, valued at
$547.2k
Exercised 31,250 options to buy
@ $0 |
|
| 05/08/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 31,250 options to buy
@ $0 |
|
| 02/27/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 280,000 options to buy
@ $38.6, valued at
$10.8M
|
|
| 02/21/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $0 |
|
| 02/06/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Sold 13,532 shares
@ $42.055, valued at
$569.1k
Sold 200 shares
@ $42.02, valued at
$8.4k
Exercised 22,515 options to buy
@ $9.56, valued at
$215.2k
Exercised 330 options to buy
@ $9.56, valued at
$3.2k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Sold 976 shares
@ $42.0106, valued at
$41k
Exercised 1,620 options to buy
@ $9.56, valued at
$15.5k
|
|
| 01/20/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Sold 4,936 shares
@ $40.3959, valued at
$199.4k
Exercised 8,080 options to buy
@ $9.56, valued at
$77.2k
|
|
| 01/19/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Sold 25,446 shares
@ $40.0349, valued at
$1M
Exercised 41,920 options to buy
@ $9.56, valued at
$400.8k
|
|
| 01/13/2023 |
4/A
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 shares
@ $0
Exercised 40,000 options to buy
@ $0 |
|
| 01/13/2023 |
4/A
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Exercised 5,895 shares
@ $0
Exercised 1,380 shares
@ $33.75, valued at
$46.6k
Exercised 5,895 rights
@ $7.9, valued at
$46.6k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/15/2022 |
4
| Khattar Jack A. (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 16,300 options to buy
@ $4.53, valued at
$73.8k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2022 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Acquired 10,750 shares
@ $0
Disposed of 10,750 shares
@ $0 |
|
| 03/17/2022 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 60,000 shares
@ $0 |
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
3
| Khattar Jack A. (Director) has filed a Form 3 on COGNITION THERAPEUTICS INC |
| 07/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Khattar Jack A. (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 16,300 options to buy
@ $5.7, valued at
$92.9k
|
|
|